| Dr Frank Perry Walker Jr, PHARM D | |
|
600 W Ventura St, Fillmore, CA 93015-1925 | |
| (805) 524-9792 | |
| (805) 524-9794 |
| Full Name | Dr Frank Perry Walker Jr |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 600 W Ventura St, Fillmore, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386964559 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 44491 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank Perry Walker Jr, PHARM D 600 W Ventura St, Fillmore, CA 93015-1925 Ph: (805) 524-9792 | Dr Frank Perry Walker Jr, PHARM D 600 W Ventura St, Fillmore, CA 93015-1925 Ph: (805) 524-9792 |
News Archive
Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.
The Norwegian pharmaceutical company Lytix Biopharma AS today announced approvals from the Norwegian Medicines Agency ("Statens legemiddelverk") and the Swedish Medical Products Agency ("Läkemedelverket") to commence Phase I clinical trials of OncoporeTM (LTX-315) for the treatment of cancer.
Terminix, the leading provider of termite and pest control services in the United States, today warned of two serious mosquito-borne diseases which are being reported in Florida. The Florida Department of Health this week issued a report confirming 18 cases of chikungunya virus and 24 cases of dengue fever.
The prestigious scientific journal Clinical Cancer Research has published a study conducted by the research group led by Dr. Francesco Bertoni of the Institute of Oncology Research, that have tested a new molecule that demonstrates its ability to inhibit lymphoma growth.
Salix Pharmaceuticals, Ltd. has announced that Salix Pharmaceuticals, Inc. has filed a lawsuit in the United States District Court for the District of New Jersey against Novel Laboratories, Inc. for infringement of the patent protecting OSMOPREP (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets.
› Verified 1 days ago
Dr. Alireza Alibanaei, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 552 Sespe Ave, Fillmore, CA 93015 Phone: 805-242-4575 Fax: 818-436-0518 | |
Dr. Robert Gerald Hersh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 353 Central Ave, Fillmore, CA 93015 Phone: 805-524-0052 | |
Juley Thomas Vaidhyan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 328 Central Ave, Fillmore, CA 93015 Phone: 805-524-0052 | |
Susana Morales, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 552 Sespe Ave, Fillmore, CA 93015 Phone: 805-242-4575 |